Disease | allergic asthma |
Phenotype | C0011849|diabetes mellitus |
Sentences | 2 |
PubMedID- 25291953 | Omalizumab (anti-ige) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up. |
PubMedID- 26075226 | We showed that omalizumab therapy increases blood glucose levels in allergic asthma patients with diabetes mellitus. |
Page: 1